168 related articles for article (PubMed ID: 23724068)
1. Evolution of a potential hormone antagonist following gene splicing during primate evolution.
Deng C; Hsueh AJ
PLoS One; 2013; 8(5):e64610. PubMed ID: 23724068
[TBL] [Abstract][Full Text] [Related]
2. Unsulfated cholecystokinin: An overlooked hormone?
Rehfeld JF; Agersnap M
Regul Pept; 2012 Jan; 173(1-3):1-5. PubMed ID: 21985915
[TBL] [Abstract][Full Text] [Related]
3. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
Kennedy K; Gigoux V; Escrieut C; Maigret B; Martinez J; Moroder L; Fréhel D; Gully D; Vaysse N; Fourmy D
J Biol Chem; 1997 Jan; 272(5):2920-6. PubMed ID: 9006937
[TBL] [Abstract][Full Text] [Related]
4. Biology of gut cholecystokinin and gastrin receptors.
Shulkes A; Baldwin GS
Clin Exp Pharmacol Physiol; 1997; 24(3-4):209-16. PubMed ID: 9131287
[TBL] [Abstract][Full Text] [Related]
5. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth.
Hellmich MR; Rui XL; Hellmich HL; Fleming RY; Evers BM; Townsend CM
J Biol Chem; 2000 Oct; 275(41):32122-8. PubMed ID: 10913157
[TBL] [Abstract][Full Text] [Related]
6. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
7. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Mosher JT; Johnson MF; Birkemo LS; Ervin GN
Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
[TBL] [Abstract][Full Text] [Related]
8. Role of CCK in gallbladder function.
Schjoldager BT
Ann N Y Acad Sci; 1994 Mar; 713():207-18. PubMed ID: 8185161
[TBL] [Abstract][Full Text] [Related]
9. Evolution of gastrointestinal hormones: the cholecystokinin/gastrin family.
Baldwin GS; Patel O; Shulkes A
Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):77-88. PubMed ID: 19952740
[TBL] [Abstract][Full Text] [Related]
10. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
[TBL] [Abstract][Full Text] [Related]
11. Devazepide, a nonpeptide antagonist of CCK receptors, induces apoptosis and inhibits Ewing tumor growth.
Carrillo J; Agra N; Fernández N; Pestaña A; Alonso J
Anticancer Drugs; 2009 Aug; 20(7):527-33. PubMed ID: 19407653
[TBL] [Abstract][Full Text] [Related]
12. Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampus.
Shigeri Y; Shinohara S; Murata S; Fujimoto M; Kawasaki K
Jpn J Pharmacol; 1996 Sep; 72(1):9-15. PubMed ID: 8902594
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin expression in tumors: biogenetic and diagnostic implications.
Rehfeld JF
Future Oncol; 2016 Sep; 12(18):2135-47. PubMed ID: 27306028
[TBL] [Abstract][Full Text] [Related]
14. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
Oliver AS; Vigna SR
Gen Comp Endocrinol; 1997 Jan; 105(1):91-101. PubMed ID: 9000471
[TBL] [Abstract][Full Text] [Related]
15. Influence of gastrin on human astrocytic tumor cell proliferation.
Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
[TBL] [Abstract][Full Text] [Related]
16. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
Meyer G; Beinborn M; Sewing KF
Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion.
Spannagel AW; Green GM; Guan D; Liddle RA; Faull K; Reeve JR
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4415-20. PubMed ID: 8633081
[TBL] [Abstract][Full Text] [Related]
19. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58.
Reeve JR; McVey DC; Bunnett NW; Solomon TE; Keire DA; Ho FJ; Davis MT; Lee TD; Shively JE; Vigna SR
Pancreas; 2002 Oct; 25(3):e50-5. PubMed ID: 12370550
[TBL] [Abstract][Full Text] [Related]
20. Evolution of alternative splicing in primate brain transcriptomes.
Lin L; Shen S; Jiang P; Sato S; Davidson BL; Xing Y
Hum Mol Genet; 2010 Aug; 19(15):2958-73. PubMed ID: 20460271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
